Gene · 1133
Papers368
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 368
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Substrate-specific regulation of the mTORC1 pathway by G protein-coupled receptors. | Biochem J | 2026 | 42619181 | PubTator, text mining | PubMed |
| Structure-based prediction of muscarinic M1/M3 receptor antagonist activity: Curated dataset and scaffold-aware evaluation. | J Pharmacol Exp Ther | 2026 | 42308581 | PubTator, text mining | PubMed |
| Dequalinium-based bitopic ligands uncover distinct pharmacological modulation of muscarinic receptors. | Biochem Pharmacol | 2026 | 42061623 | PubTator, text mining | PubMed |
| Exploring Genetic Heterogeneity in Type 2 Diabetes Subtypes. | Genes (Basel) | 2025 | 41153348 | PubTator, text mining | PubMed |
| Decreased non-neurogenic acetylcholine in bone marrow triggers age-related defective stem/progenitor cell homing. | Nat Commun | 2025 | 40593589 | PubTator, text mining | PubMed |
| Modulatory effects of M3 muscarinic acetylcholine receptor on inflammatory profiles of human memory T helper cells. | J Immunol | 2025 | 40405417 | PubTator, text mining | PubMed |
| Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression. | J Psychopharmacol | 2025 | 40129096 | PubTator, text mining | PubMed |
| Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches. | Comput Biol Chem | 2025 | 39938415 | PubTator, text mining | PubMed |
| Epigenetic Modification of Muscarinic Acetylcholine Receptors in Squamous Cell Carcinoma of the Head and Neck. | Anticancer Res | 2025 | 39740827 | PubTator, text mining | PubMed |
| The Role of Aryl Hydrocarbon Receptor in Bone Biology. | Int J Tryptophan Res | 2024 | 38757095 | PubTator, text mining | PubMed |
Exploring the therapeutic mechanism of potential phytocompounds from Kalanchoe pinnata in the treatment of diabetes mellitus by integrating network pharmacology, molecular docking and simulation approach. | Saudi Pharm J | 2024 | 38550331 | PubTator, text mining | PubMed |
| Early parental deprivation during primate infancy has a lifelong impact on gene expression in the male marmoset brain. | Sci Rep | 2024 | 38172165 | PubTator, text mining | PubMed |
| Potential of olfactory neuroepithelial cells as a model to study schizophrenia: A focus on GPCRs (Review). | Int J Mol Med | 2024 | 38038161 | PubTator, text mining | PubMed |
| Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance. | Mol Oncol | 2024 | 37842807 | PubTator, text mining | PubMed |
| The Role of Gene Fusions in Thymic Epithelial Tumors. | Cancers (Basel) | 2023 | 38067300 | PubTator, text mining | PubMed |
| Acetylcholine, Another Factor in Breast Cancer. | Biology (Basel) | 2023 | 37998017 | PubTator, text mining | PubMed |
| Exploring the potential mechanism of Kaixinsan powder for the same pathogenesis of PTSD and anxiety based on network pharmacology and molecular docking: A review. | Medicine (Baltimore) | 2023 | 37986356 | PubTator, text mining | PubMed |
| The mitotic cell cycle-associated nomogram predicts overall survival in lung adenocarcinoma. | Cancer Med | 2023 | 37930238 | PubTator, text mining | PubMed |
| Selective Activation of M1 Muscarinic Receptors Attenuates Human Colon Cancer Cell Proliferation. | Cancers (Basel) | 2023 | 37835460 | PubTator, text mining | PubMed |
| Mild replication stress causes premature centriole disengagement via a sub-critical Plk1 activity under the control of ATR-Chk1. | Nat Commun | 2023 | 37773176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1133/papers